35 results
8-K
EX-10.1
ARVN
Arvinas Inc
27 Nov 23
Arvinas Announces Oversubscribed $350 Million Private Placement
7:11am
, manufacturer, customer or contractor of the Company, exists or, to the Company’s Knowledge, is threatened or imminent.
4.14. Intellectual Property
S-3ASR
ARVN
Arvinas Inc
7 Nov 23
Automatic shelf registration
5:24pm
of beneficial interests in a global security held through participants will be governed by standing customer instructions and customary practices, as is now
424B5
weqv4yd1tx7h6mz85
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-10.1
8vwyf5lfvwfv23 yjhi0
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
424B5
k1f ti38juc
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
xkmox8mx96
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
kgz2n282j94h 882h
14 Dec 20
Automatic shelf registration
4:02pm
424B5
aewr7
7 Nov 19
Prospectus supplement for primary offering
4:05pm